Flucytosine Capsule
Product Images NDC 43386-770

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Flucytosine (NDC 43386-770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F4124aa5 Ff56 4daa 9f77 Fff2bfea8227 01

FDA Label Image

F4124aa5 Ff56 4daa 9f77 Fff2bfea8227 02

F4124aa5 Ff56 4daa 9f77 Fff2bfea8227 02
Each capsule of NDC 43386-771-03 contains 250 mg of flucytosine and is manufactured by Novel Laboratories, Inc. The medication is intended to be dispensed in a tight, light-resistant container with a child-resistant closure as defined in Somerset, NJ 08873. Flucytosine is approved by the US Pharmacopeial Convention (USP) and is manufactured for Lupin Pharmaceuticals, Inc. Proper storage requires keeping the capsules at 25°C (77°F) with excursions permitted. Additional important prescribing information can be found on the packaging. The unvarnished area G measures 16 mm X 55 mm.*
FDA Label Image

F4124aa5 Ff56 4daa 9f77 Fff2bfea8227 03

F4124aa5 Ff56 4daa 9f77 Fff2bfea8227 03
Flucytosine Capsules, USP containing 500mg of flucytosine. The medication is manufactured by Novel Laboratories, Inc. and is dispensed in a container with child-resistant closure. The recommended storage temperature is between 15°C and 30°C. Please read the accompanying insert for dosage recommendations and other important prescribing information. The product is distributed by Lupin Pharmaceuticals, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.